Emyria Secures First DVA Treatment Approvals as Veteran Referrals Exceed 40
The Australian psychedelic-assisted therapy provider has reported record quarterly revenue of $1.42 million, expanded its national clinic network and received ...
The Australian psychedelic-assisted therapy provider has reported record quarterly revenue of $1.42 million, expanded its national clinic network and received ...
Red Light Holland subsidiary Filament Health will supply its naturally derived psilocybin drug candidate, PEX010, for a new clinical trial ...
Psychedelics.media delivers trusted news, intelligence, and insights for the global psychedelic medicine industry.
